Is This the Secret Ingredient That Could Make Moderna Shareholders Rich?
With the advances in both software and hardware, investors are recognizing that every company is a technology company. Rather than a back office function supporting a few productivity tools, technology has become a differentiator in industries that may seem to have little to do with software and semiconductors. In the biotech industry, Moderna (NASDAQ: MRNA) recognized this from the start.